Abstract
4-Methylthioamphetamine (4-MTA) is recognised as a 3,4-methylenedioxymethamphetamine (MDMA)-like drug of abuse. Such amphetamine-type drugs often contain byproducts of uncontrolled, illegal clandestine synthetic processes. We report the isolation and structural identification of a number of novel pyridines, dihydropyridone and N,N-di(1-aryl-2-propyl) amines as route-specific byproducts associated with clandestine synthesis of 4-MTA and related amphetamines. We report the in vitro cytotoxicity of 4-MTA, its synthesis byproducts together with some structurally related sulfur substituted α-alkyl phenethylamines in cell lines overexpressing human monoamine transporters as well as in a primary neuronal cell line model and a dopaminergic neuroblastoma cell line. 4-MTA along with a number of other structurally related amphetamine derivatives and synthetic impurities were found to be cytotoxic to these cells within pharmacologically defined concentrations implying that 4-MTA is a cytotoxic agent in vitro and therefore might have the potential to be a neurotoxic agent in vivo.
| Original language | English |
|---|---|
| Pages (from-to) | 4009-4031 |
| Number of pages | 23 |
| Journal | Bioorganic and Medicinal Chemistry |
| Volume | 18 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Jun 2010 |
| Externally published | Yes |
Keywords
- 4-Methylthioamphetamine (4-MTA)
- Clandestine synthesises
- Impurity profiling
- Leuckart reaction
- Toxicity profiling